/

Empresas

Dy

No verificado

Dyno Therapeutics, Inc.

Sobre qué escribimos

BiotecnologíaEventosIndustriaSaludTécnica

10 Comunicados de prensa

Ver todos los comunicados de prensa

27/04/2026

Eventos

Salud

Técnica

Biotecnología

Farmacéutica

Dyno Therapeutics to Present New Capsids and AI Advancements in Gene Delivery at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Fuente

Dyno Therapeutics, Inc.

Editor

1.00

0

08/04/2026

Mercado laboral

Industria

Salud

Técnica

Biotecnología

Dyno Therapeutics Announces Capsid License Exercised by Astellas for Skeletal Muscle-Targeted Gene Delivery, Validating AI-Powered Technology for Biological Sequence Design

Fuente

Dyno Therapeutics, Inc.

Editor

1.00

0

18/03/2026

Eventos

Ferias y Congresos

Tecnología de la información

Biotecnología

Técnica

Salud

Sanidad

Farmacéutica

Ciencia

Software

Dyno Therapeutics Launches Dyno Psi-Phi, an Agentic AI Suite for Protein Binder Design, at NVIDIA GTC 2026

Fuente

Dyno Therapeutics, Inc.

Editor

1.00

0

12/01/2026

Técnica

Ciencia

Biotecnología

Salud

Farmacéutica

Industria

Dyno Therapeutics Launches Dyno-yp2, a Top-Performing TfR1-Mediated AAV Capsid, to Further Diversify CNS Delivery Portfolio

Fuente

Dyno Therapeutics, Inc.

Editor

1.00

0

11/11/2025

Técnica

Ciencia

Biotecnología

Medicina - Varios

Salud

Eventos

Industria

Dyno Therapeutics Unveils Best-in-Class Dyno-bn8 AAV Vector for Muscle Gene Therapies, Achieving Therapeutic Delivery With Improved Safety Potential

Fuente

Dyno Therapeutics, Inc.

Editor

1.00

0

11/11/2025

Mercado laboral

Eventos

Industria

Ciencia

Biotecnología

Medicina - Varios

Salud

Farmacéutica

Dyno Therapeutics and Trisk Bio Announce Strategic Manufacturing Partnership Through Expanded Frontiers Program

Fuente

Dyno Therapeutics, Inc.

Editor

1.00

0

14/05/2025

Eventos

Industria

Salud

Técnica

Biotecnología

Dyno Therapeutics Announces Inaugural 2025 Genetic Agency Technology Conference and Launch of Dyno Frontiers Program to Accelerate Progress in Patient-Empowering Gene Therapies

Fuente

Dyno Therapeutics, Inc.

Editor

1.00

0

14/05/2025

Eventos

Industria

Biotecnología

Salud

Dyno Therapeutics Launches Three Breakthrough Capsid Delivery Vectors for Next-Generation Eye, Muscle and CNS Gene Therapies at the 2025 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Fuente

Dyno Therapeutics, Inc.

Editor

1.00

0

28/04/2025

Eventos

Ferias y Congresos

Industria

Salud

Técnica

Biotecnología

Farmacéutica

Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy

Fuente

Dyno Therapeutics, Inc.

Editor

1.00

0

13/01/2025

Mercado laboral

Industria

Salud

Técnica

Biotecnología

Dyno Therapeutics Announces Exercise of Option by Roche for Next-Generation AAV Vector for Neurological Gene Therapy

Fuente

Dyno Therapeutics, Inc.

Editor

1.00

0

Seguidores

0

Compatibilidad

0